Literature DB >> 15751980

Efficacy of soluble phospholipids in the prothrombinase reaction.

Matthew D Stone1, Gary L Nelsestuen.   

Abstract

The prothrombinase complex is comprised of an enzyme, factor Xa, and a cofactor, factor Va, that each bind peripherally to membranes containing phosphatidylserine (PS) and activate the substrate, prothrombin. The mechanism by which the membrane contributes to enhanced catalytic efficacy of prothrombinase is not precisely known but is generally attributed to some aspect of enzyme and substrate assembly on the multisite surface of the membrane. A recent proposal has suggested a radically different role in which individual phospholipid molecules, either in the membrane or as single soluble molecules, act by an entirely allosteric mechanism that does not involve the multisite feature of the membrane [Zhai, X., Srivastava, A., Drummond, D. C., Daleke, D., and Lentz, B. R. (2002) Biochemistry 41, 5675-5684]. Our study measured prothrombinse activity in the presence of phospholipids such as short-chain phosphatidylserine and lysophosphatidylserine (lyso-PS). Both enhanced prothrombinase activity, and the increase was consistent with the requirement for extended bilayer structure. Even then, prothrombinase activity was low when compared with activity on bilayer membranes of mixed PS and phosphatidylcholine (PC). Lyso-PS approached the activity of PS/PC membranes only when it was mixed with PC bilayers. The results suggest that the two-dimensional membrane bilayer surface is necessary for the support of full prothrombinase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15751980     DOI: 10.1021/bi047655n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

Review 1.  Emerging roles for lysophosphatidylserine in resolution of inflammation.

Authors:  S Courtney Frasch; Donna L Bratton
Journal:  Prog Lipid Res       Date:  2012-03-29       Impact factor: 16.195

2.  Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.

Authors:  Hiroshi Deguchi; Darlene J Elias; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20

3.  X-Linked Immunodeficient Mice With No Functional Bruton's Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure.

Authors:  Caroline E O'Riordan; Gareth S D Purvis; Debora Collotta; Nadine Krieg; Bianka Wissuwa; Madeeha H Sheikh; Gustavo Ferreira Alves; Shireen Mohammad; Lauren A Callender; Sina M Coldewey; Massimo Collino; David R Greaves; Christoph Thiemermann
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

4.  Coenzyme A Restriction as a Factor Underlying Pre-Eclampsia with Polycystic Ovary Syndrome as a Risk Factor.

Authors:  Charlie Hodgman; Gulafshana Hafeez Khan; William Atiomo
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

5.  Kinetic regulation of the binding of prothrombin to phospholipid membranes.

Authors:  Emma Smith; Rina Vekaria; Katherine A Brown; Colin Longstaff
Journal:  Mol Cell Biochem       Date:  2013-06-28       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.